Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (325)	9/26/1999 8:51:00 PM
From: Bob L	Respond to of 666

I haven't staked my professional reputation on CLTR because I haven't got one, at least not in biotech. But I've followed this issue pretty closely for a couple of years. While you are waiting for the smart people to respond, I'll say I've added at 18 and at 17. Seems like I should have waited, though, as it appears we are going to have a good look around the basement for a while. I hope we don't have to dig up the foundation too. By the way, we didn't all "love" it at $35. I wrote calls and bought puts at that price. It seemed sort of rich at the time. But this dance with the FDA hasn't changed the odds of approval in my view. Its just made buyers wary because who knows where the short term bottom is. I agree, this is a fascinating story. I feel like I'm really learning something. I just wish I knew what.

To: rkrw who wrote (325)	9/26/1999 9:10:00 PM
From: LLCF	Respond to of 666

< CLTR would also seem like a natural takeout candidate to me.> Thanks for the info. <There's some smart people here that know the story well, I'd like to know if they're taking their losses, playing it safe by hedging or going for it. > If you had asked this way in the beginning you wouldn't have gotten any flak. :)... going to be interesting and educational no matter what happens. DAK

To: rkrw who wrote (325)	9/27/1999 1:14:00 AM
From: Vector1	Read Replies (1) \| Respond to of 666

rkw, As noted by others I thought I was clear. I had not added to the CLTR position in the VD portfolio for a number of reasons. First from a portfolio management standpoint we already had a large CLTR position. Second, I stated before the refuse to file letter from the FDA that if the shorts were right and there was something wrong with the filing the stock would drop like a rock. I just did not think there was anything wrong with the filing. Boy was I wrong. However, with the price hovering at $15 I couldn't wait any longer. See Message 11368664 I have not said much lately because while we await the refiling and ASH there is not much to say. The shorts have been right so far and I do not have any new information. Rit is a great drug and combo therapy with CHOP is a major advance in treatment of low grade nontransformed NHL. However, there is room for Bexxar and I believe it will be approved. IF the Bexxar plus Fludarbine trials show better results than Rit plus CHOP it is a huge homerun. We will see. V1